1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Paul Potnuru: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury Vadadustat 900mg, Vadadustat 1200mg, Placebo - Nonintubated Acute Respiratory Distress Syndrome (ARDS), Pathogen-associated Lung Injury | Phase 2 / Phase 3 | Recruiting | Paul Potnuru | 1100 | 2025-10-23 | 2026-08-10 |
vadadustat (1)
United States (1)